Waukegan, IL, United States of America

Steven E Lunetta

This inventor holds 3 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1992-1998.


% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 1992-1998

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Steven E Lunetta

Introduction

Steven E Lunetta is a notable inventor based in Waukegan, IL (US). He has made significant contributions to the field of immunoassay reagents, particularly in the determination of cyclosporine. With a total of 3 patents to his name, Lunetta's work has advanced the methodologies used in medical diagnostics.

Latest Patents

Lunetta's latest patents focus on immunoassay reagents and methods for determining cyclosporine. These patents disclose cyclosporine derivatives that serve as detectable tracer compounds for the immunoassay determination of cyclosporine. The derivatives include a detectable moiety coupled to various amino acids in cyclosporine, such as MeBmt, Abu, Sar, D-Ala, and MeLeu. A preferred derivative features a fluorescent moiety attached to the hydroxyl group of the amino acid at the first position in cyclosporine, making it particularly useful for fluorescent polarization immunoassay methods and test kits.

Career Highlights

Lunetta is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative solutions in immunoassay technology, contributing to advancements in patient care and diagnostics.

Collaborations

Some of Lunetta's notable coworkers include Elizabeth A Simpson and Mariola B Zajac. Their collaborative efforts have further enhanced the research and development of immunoassay reagents.

Conclusion

Steven E Lunetta's contributions to the field of immunoassay reagents have made a significant impact on medical diagnostics. His innovative patents and collaborations continue to shape the future of healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…